MedX Health Corp (MDXHF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -3.02 Million CAD | 21.8% |
| 2022 | -3.86 Million CAD | 15.22% |
| 2021 | -4.56 Million CAD | -50.61% |
| 2020 | -3.02 Million CAD | 3.23% |
| 2019 | -3.13 Million CAD | 23.36% |
| 2018 | -4.08 Million CAD | -173.38% |
| 2017 | -1.49 Million CAD | -22.46% |
| 2016 | -1.22 Million CAD | -79.01% |
| 2015 | -681.6 Thousand CAD | -22.69% |
| 2014 | -555.55 Thousand CAD | 39.8% |
| 2013 | -922.88 Thousand CAD | 30.19% |
| 2012 | -1.32 Million CAD | -54.91% |
| 2011 | -853.36 Thousand CAD | 14.03% |
| 2010 | -992.57 Thousand CAD | 61.12% |
| 2009 | -2.55 Million CAD | 4.93% |
| 2008 | -2.68 Million CAD | -26.92% |
| 2007 | -2.11 Million CAD | -72.26% |
| 2006 | -1.22 Million CAD | 29.8% |
| 2005 | -1.74 Million CAD | -437.15% |
| 2004 | -325.73 Thousand CAD | 65.12% |
| 2003 | -933.79 Thousand CAD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -736.3 Thousand CAD | 1.87% |
| 2024 Q1 | -750.32 Thousand CAD | -19.25% |
| 2023 FY | -3.02 Million CAD | 21.8% |
| 2023 Q4 | -629.22 Thousand CAD | 23.81% |
| 2023 Q2 | -786.11 Thousand CAD | -1.59% |
| 2023 Q1 | -773.77 Thousand CAD | 21.38% |
| 2023 Q3 | -825.88 Thousand CAD | -5.06% |
| 2022 FY | -3.86 Million CAD | 15.22% |
| 2022 Q2 | -1.02 Million CAD | -4.63% |
| 2022 Q4 | -984.16 Thousand CAD | -12.03% |
| 2022 Q1 | -980.18 Thousand CAD | 12.36% |
| 2022 Q3 | -878.49 Thousand CAD | 14.34% |
| 2021 FY | -4.56 Million CAD | -50.61% |
| 2021 Q4 | -1.11 Million CAD | 19.48% |
| 2021 Q1 | -935.79 Thousand CAD | -43.82% |
| 2021 Q2 | -1.11 Million CAD | -19.65% |
| 2021 Q3 | -1.38 Million CAD | -24.05% |
| 2020 FY | -3.02 Million CAD | 3.23% |
| 2020 Q1 | -617.59 Thousand CAD | 46.37% |
| 2020 Q4 | -650.68 Thousand CAD | 39.32% |
| 2020 Q2 | -688.79 Thousand CAD | -11.53% |
| 2020 Q3 | -1.07 Million CAD | -55.69% |
| 2019 Q2 | -688.56 Thousand CAD | 8.08% |
| 2019 Q3 | -541.22 Thousand CAD | 21.4% |
| 2019 FY | -3.13 Million CAD | 23.36% |
| 2019 Q4 | -1.15 Million CAD | -112.77% |
| 2019 Q1 | -749.08 Thousand CAD | 25.7% |
| 2018 Q3 | -890.15 Thousand CAD | 42.54% |
| 2018 Q4 | -1 Million CAD | -13.25% |
| 2018 FY | -4.08 Million CAD | -173.38% |
| 2018 Q1 | -637.42 Thousand CAD | -136.0% |
| 2018 Q2 | -1.54 Million CAD | -143.02% |
| 2017 Q4 | -270.09 Thousand CAD | 48.89% |
| 2017 Q1 | -316.39 Thousand CAD | -12.57% |
| 2017 Q2 | -379.22 Thousand CAD | -19.86% |
| 2017 FY | -1.49 Million CAD | -22.46% |
| 2017 Q3 | -528.45 Thousand CAD | -39.35% |
| 2016 Q2 | -287.49 Thousand CAD | -42.01% |
| 2016 Q1 | -202.45 Thousand CAD | 44.7% |
| 2016 Q3 | -449.14 Thousand CAD | -56.22% |
| 2016 FY | -1.22 Million CAD | -79.01% |
| 2016 Q4 | -281.05 Thousand CAD | 37.42% |
| 2015 FY | -681.6 Thousand CAD | -22.69% |
| 2015 Q1 | -45.37 Thousand CAD | 88.4% |
| 2015 Q4 | -366.07 Thousand CAD | -62.94% |
| 2015 Q3 | -224.67 Thousand CAD | -397.73% |
| 2015 Q2 | -45.14 Thousand CAD | 0.52% |
| 2014 FY | -555.55 Thousand CAD | 39.8% |
| 2014 Q3 | 346.51 Thousand CAD | 222.51% |
| 2014 Q2 | -282.84 Thousand CAD | -23.96% |
| 2014 Q1 | -228.17 Thousand CAD | -153.94% |
| 2014 Q4 | -391.04 Thousand CAD | -212.85% |
| 2013 Q1 | -298.3 Thousand CAD | 15.77% |
| 2013 Q4 | -89.85 Thousand CAD | 77.22% |
| 2013 FY | -922.88 Thousand CAD | 30.19% |
| 2013 Q2 | -140.34 Thousand CAD | 52.95% |
| 2013 Q3 | -394.37 Thousand CAD | -181.01% |
| 2012 FY | -1.32 Million CAD | -54.91% |
| 2012 Q4 | -354.15 Thousand CAD | -7.75% |
| 2012 Q3 | -328.67 Thousand CAD | 6.78% |
| 2012 Q2 | -352.57 Thousand CAD | -10.74% |
| 2012 Q1 | -318.38 Thousand CAD | -70.95% |
| 2011 Q4 | -186.24 Thousand CAD | 30.59% |
| 2011 Q2 | -185.2 Thousand CAD | 13.26% |
| 2011 Q1 | -213.51 Thousand CAD | -9.01% |
| 2011 FY | -853.36 Thousand CAD | 14.03% |
| 2011 Q3 | -268.31 Thousand CAD | -44.88% |
| 2010 Q1 | -248.83 Thousand CAD | 78.68% |
| 2010 FY | -992.57 Thousand CAD | 61.12% |
| 2010 Q2 | -279.39 Thousand CAD | -12.28% |
| 2010 Q3 | -303.83 Thousand CAD | -8.75% |
| 2010 Q4 | -195.87 Thousand CAD | 35.53% |
| 2009 Q2 | -538.97 Thousand CAD | -15.08% |
| 2009 Q1 | -468.36 Thousand CAD | 24.82% |
| 2009 FY | -2.55 Million CAD | 4.93% |
| 2009 Q3 | -378.4 Thousand CAD | 29.79% |
| 2009 Q4 | -1.16 Million CAD | -208.46% |
| 2008 Q4 | -622.99 Thousand CAD | 3.25% |
| 2008 Q3 | -643.92 Thousand CAD | 18.08% |
| 2008 Q1 | -632.45 Thousand CAD | 18.3% |
| 2008 Q2 | -786.04 Thousand CAD | -24.29% |
| 2008 FY | -2.68 Million CAD | -26.92% |
| 2007 Q2 | -495.22 Thousand CAD | 9.04% |
| 2007 Q1 | -544.46 Thousand CAD | -7.79% |
| 2007 Q3 | -301.24 Thousand CAD | 39.17% |
| 2007 Q4 | -774.14 Thousand CAD | -156.98% |
| 2007 FY | -2.11 Million CAD | -72.26% |
| 2006 Q2 | -171.04 Thousand CAD | -76.81% |
| 2006 Q1 | -96.73 Thousand CAD | 88.44% |
| 2006 FY | -1.22 Million CAD | 29.8% |
| 2006 Q3 | -554.17 Thousand CAD | -224.0% |
| 2006 Q4 | -505.1 Thousand CAD | 8.85% |
| 2005 Q4 | -836.94 Thousand CAD | -72.2% |
| 2005 FY | -1.74 Million CAD | -437.15% |
| 2005 Q1 | -175.35 Thousand CAD | 19.19% |
| 2005 Q2 | -188.51 Thousand CAD | -7.51% |
| 2005 Q3 | -486.04 Thousand CAD | -157.82% |
| 2004 FY | -325.73 Thousand CAD | 65.12% |
| 2004 Q1 | -121.32 Thousand CAD | 0.0% |
| 2004 Q3 | -77.6 Thousand CAD | -157.67% |
| 2004 Q4 | -216.99 Thousand CAD | -179.62% |
| 2004 Q2 | 134.56 Thousand CAD | 210.91% |
| 2003 FY | -933.79 Thousand CAD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Manhattan Scientifics, Inc. | -703 Thousand USD | -330.3% |
| Össur hf. | 87.46 Million USD | 103.459% |
| QHSLab, Inc. | -240.15 Thousand USD | -1159.592% |
| Wellstar International, Inc. | -1.79 Million USD | -68.553% |
| Össur hf. | 87.46 Million USD | 103.459% |
| Bionovate Technologies Corp | - USD | Infinity% |
| Escalon Medical Corp. | -104.47 Thousand USD | -2795.412% |
| Aurora Spine Corporation | -446.19 Thousand USD | -577.956% |
| BrainsWay Ltd. | -4.92 Million USD | 38.603% |
| Lattice Biologics Ltd. | - USD | Infinity% |
| AVITA Medical, Inc. | -40.4 Million USD | 92.513% |
| CVR Medical Corp. | - USD | Infinity% |
| Hamilton Thorne Ltd. | 277.99 Thousand USD | 1188.145% |
| BioElectronics Corporation | -274.29 Thousand USD | -1002.851% |
| Vivos Inc. | -2.79 Million USD | -8.301% |
| Kelyniam Global, Inc. | -239.16 Thousand USD | -1164.816% |
| Zecotek Photonics Inc. | -3.65 Million USD | 17.276% |
| REMSleep Holdings, Inc. | -1.77 Million USD | -70.746% |
| EKF Diagnostics Holdings plc | 2.08 Million USD | 245.363% |
| Avitar, Inc. | 2.73 Million USD | 210.692% |
| Nanomix Corporation | -8.43 Million USD | 64.147% |
| Theraclion SA | -3.48 Million USD | 13.097% |
| Lifeline Biotechnologies, Inc. | - USD | Infinity% |
| Wellness Center USA, Inc. | -707.02 Thousand USD | -327.849% |
| NewCardio, Inc. | -9.45 Million USD | 68.021% |
| Positron Corporation | -1.36 Million USD | -122.305% |
| Rafina Innovations Inc. | - USD | Infinity% |
| Electromedical Technologies, Inc. | -2.06 Million USD | -46.494% |
| Lombard Medical, Inc. | -29.33 Million USD | 89.688% |
| ALR Technologies Inc. | -2.94 Million USD | -2.671% |
| Stratec SE | 25.26 Million USD | 111.972% |
| Vycor Medical, Inc. | 40.19 Thousand USD | 7626.588% |
| Heart Tronics, Inc. | 14.46 Million USD | 120.92% |
| Nu-Med Plus, Inc. | -120.52 Thousand USD | -2409.841% |
| MicroPort Scientific Corporation | -516.16 Million USD | 99.414% |
| VMS Rehab Systems, Inc. | -68.66 USD | -4405683.571% |
| Guided Therapeutics, Inc. | -3.45 Million USD | 12.496% |
| Ingen Technologies, Inc. | -1.61 Million USD | -87.465% |
| CYduct Diagnostics, Inc. | -378.9 Thousand USD | -698.354% |
| Odyssey Group International, Inc. | 14.26 Million USD | 121.212% |
| SANUWAVE Health, Inc. | -540 Thousand USD | -460.187% |
| IR-Med Inc. | -4.91 Million USD | 38.403% |
| Perimeter Medical Imaging AI, Inc. | -20.72 Million USD | 85.407% |
| United American Healthcare Corporation | -67 Thousand USD | -4414.942% |
| Polarean Imaging plc | -12.55 Million USD | 75.908% |
| ECGI Holdings, Inc. | -407.48 Thousand USD | -642.37% |
| Capital Group Holdings, Inc. | -634.68 Thousand USD | -376.614% |
| ADM Tronics Unlimited, Inc. | -601.52 Thousand USD | -402.894% |
| Medical Supply International USA, Inc. | 438.18 Thousand USD | 790.358% |
| Rapid Therapeutic Science Laboratories, Inc. | -1.26 Million USD | -139.447% |
| Nexeon MedSystems Inc. | -6.26 Million USD | 51.716% |
| SS Innovations International, Inc. | -20.66 Million USD | 85.364% |
| Urologix, Inc. | -6.93 Million USD | 56.349% |
| Qualis Innovations, Inc. | -230.24 Thousand USD | -1213.845% |
| Smith & Nephew plc | 425 Million USD | 100.712% |
| NIOX Group Plc | 4.6 Million USD | 165.761% |
| Fuse Medical, Inc. | 383.82 Thousand USD | 888.133% |
| Broncus Holding Corporation | -33.22 Million USD | 90.894% |
| Brain Scientific Inc. | -9.6 Million USD | 68.517% |
| Pressure BioSciences, Inc. | -9.5 Million USD | 68.169% |
| Health Logic Interactive Inc. | -60.69 Thousand USD | -4883.626% |